Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-08-20

Clinical Trial Update: Cryptococcal Optimal ART Timing Trial [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the timing of antiretroviral therapy in cryptococcal meningitis with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Minnesota | Conditions: Cryptococcal Meningitis, HIV Infections | Phase 4 | Status: COMPLETED | Results posted: 2014-08-20